MedTech Jam Session with Chris and Mike D
MedTech Jam Session with Chris and Mike D
Mike Donoghue and Chris Lyons
Cytex Ortho | Brad Estes
39 minutes Posted Jun 24, 2025 at 9:00 am.
0:00
39:19
Download MP3
Show notes

Can We Grow New Cartilage Instead of Replacing Joints? That’s a gamechanger! Brad Estes, CEO of CytexOrtho, joined Chris and I on the MedTech Jam Session to talk about his 3D printed biodegradable scaffold designed to replace damaged cartilage. Here’s what we learned from Brad:

1. Solving the Young Patient Gap With no good solution between cartilage repair and total joint replacement, Cytex targets a major unmet need: 35–60-year-old active patients who need lasting results without compromising future treatment options. That would be HUGE!

2. Leveraging NIH-Funded Research Originally developed at Duke University, Cytex has leveraged over $18M in non-dilutive funding. Super resourceful management team.

3. 3D Printing continues to be a great technology platform The Cytex team have developed a 3D printed manufacturing process for a complex, mechanically strong biodegradable scaffold. Impressive.

Follow Cytex Ortho and Brad Estes on LinkedIn

Listen to this episode wherever you get your podcasts!

Apple

Spotify